计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| O648722-5mg |
5mg |
期货 ![]() |
| |
| O648722-10mg |
10mg |
期货 ![]() |
| |
| O648722-25mg |
25mg |
期货 ![]() |
| |
| O648722-50mg |
50mg |
期货 ![]() |
| |
| O648722-100mg |
100mg |
期货 ![]() |
|
| 别名 | 磷酸奥司他 |
|---|---|
| 英文别名 | Osilodrostat phosphate | Q27294304 | CHEMBL3707393 | Osilodrostat (phosphate) | AKOS040749099 | Osilodrostat phosphate [USAN] | Osilodrostat phosphate (JAN/USAN) | Isturisa (TN) | D11062 | UNII-Y6581YAW9V | DTXSID401027857 | 4-[(5R)-6,7-dihydro-5H-pyrrolo |
| 规格或纯度 | ≥99% |
| 英文名称 | Osilodrostat phosphate |
| 生化机理 | Osilodrostat(LCI699)磷酸盐是一种强效的口服活性 11β-hydroxylase (CYP11B1) 抑制剂,IC 50 值为 35 nM。Osilodrostat 磷酸酯是一种强效的口服醛固酮合成酶(CYP11B2)抑制剂,对人类和哺乳动物的 IC 50 值分别为 0.7 nM 和 160 nM。 |
| 储存温度 | 2-8°C储存,干燥 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 细胞色素 P450 11B1 抑制剂 |
| 产品介绍 |
Osilodrostat (LCI699) phosphate is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC 50 value of 35 nM. Osilodrostat phosphate is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC 50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat phosphate inhibits aldosterone and corticosterone synthesis. Osilodrostat phosphate has blood pressure lowering ability. Osilodrostat phosphate can be used for research of Cushing syndrome (CS) In Vitro Osilodrostat (LCI699; 0.01-10 µM; HAC15 cells, 17 primary human adrenocortical cell cultures, and pituitary adenoma cells) phosphate inhibits cortisol and aldosterone. Osilodrostat results in inhibition of corticosterone, 11-deoxycortisol accumulation, and modest effects on adrenal androgens. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Osilodrostat (LCI699; 0.1-100 mg/kg; p.o.; once) phosphate inhibits aldosterone and corticosterone synthesis in Ang-II- and ACTH-stimulated Sprague Dawley rats . Osilodrostat (LCI699; 3-100 mg/kg; p.o.; daily, for 52 weeks) phosphate reduces mean arterial pressure and prolongs survival in dTG rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Ang-II- and ACTH-stimulated Sprague Dawley rats Dosage: 0.1, 0.3, 1 and 3 mg/kg (Ang-II-stimulated rats) and 1, 3, 10, 30 and 100 mg/kg (ACTH-stimulated rats) Administration: Oral administration; once Result: Inhibited the increase in plasma aldosterone concentrations stimulated by Ang II or ACTH in a dose-dependent manner. Animal Model: dTG rats Dosage: 3, 10, 30 and 100 mg/kg Administration: Oral administration; daily, for 52 weeks Result: Increased fractional LV (systolic and diastolic) shortening, normalized LV isovolumic relaxation time to RR (IVRT/RR) ratio and myocardial cell size and reduced LV weight in a dose-dependent manner. Form:Solid IC50& Target:IC50: 35 nM (CYP11B1), 0.7 nM (human aldosterone synthase), and 160 nM (rat aldosterone synthase) |
| 纯度 | ≥99% |
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile;phosphoric acid |
| INCHI | 1S/C13H10FN3.H3O4P/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13;1-5(2,3)4/h1,3,5,7-8,13H,2,4H2;(H3,1,2,3,4)/t13-;/m1./s1 |
| InChi Key | FMCPYRDGUZBOJZ-BTQNPOSSSA-N |
| Smiles | C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F.OP(=O)(O)O |
| Isomeric SMILES | C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F.OP(=O)(O)O |
| PubChem CID | 71009737 |
| 分子量 | 325.23 |
| 溶解性 | H2O : ≥ 200 mg/mL (614.95 mM) |
|---|---|
| 分子量 | 325.230 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 1 |
| 精确质量Exact Mass | 325.063 Da |
| 单同位素质量Monoisotopic Mass | 325.063 Da |
| 拓扑极表面积Topological Polar Surface Area | 119.000 Ų |
| 重原子数Heavy Atom Count | 22 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 387.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |